Plasmonic Functional Assay Platform for Measuring Single Cell Growth through Refractive Index Sensing
| dc.contributor.author | Avci, M.B. | |
| dc.contributor.author | Topkaya, S.N. | |
| dc.contributor.author | Yalcin-Ozuysal, O. | |
| dc.contributor.author | Khademhosseini, A. | |
| dc.contributor.author | Çetin, A.E. | |
| dc.date.accessioned | 2023-11-11T08:54:54Z | |
| dc.date.available | 2023-11-11T08:54:54Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Measuring cell growth on adhesive substrates is critical for understanding cell biophysical properties and drug response. Traditional optical techniques have low sensitivity and vary in reliability depending on cell type, while microfluidic technologies rely on cell suspension. In this study, a new platform has been developed that is able to measure the weight and growth of individual cells in real−time. The platform can determine the growth rates of cells in just 10 minutes and map the growth of cell populations in short intervals. It can also identify differences in the growth of different subpopulations within a larger group. The platform was used to study the growth of MCF−7 cells and the impact of two intracellular metabolic processes on cell proliferation. The platform demonstrated the negative effect of serum starvation on cell growth and the role of a particular enzyme, ornithine decarboxylase (ODC), in cell proliferation. It was also able to show the ability of an external factor, putrescine, to rescue cells from the inhibitory effects of low osmolarity. In addition to measuring intracellular processes, the platform can determine the response of cancer cells to drug treatment. It showed the susceptibility of MCF−7 cells to a particular drug, difluoromethylornithine (DFMO), and the ability of a resistant subpopulation to survive in the presence of the drug. The platform’s ability to quickly measure cell growth in small samples makes it a potential tool for both research and clinical use. © 2023 SPIE. | en_US |
| dc.identifier.doi | 10.1117/12.2670999 | |
| dc.identifier.isbn | 9781510664630 | |
| dc.identifier.issn | 0277-786X | |
| dc.identifier.scopus | 2-s2.0-85214793387 | |
| dc.identifier.uri | https://doi.org/10.1117/12.2670999 | |
| dc.language.iso | en | en_US |
| dc.publisher | Optical Society of America | en_US |
| dc.relation.ispartof | European Conference on Biomedical Optics, ECBO 2023 -- 2023 European Conference on Biomedical Optics, ECBO 2023 -- 2023-06-25 through 2023-06-29 -- Munich -- 205071 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Cellular Metabolism | en_US |
| dc.subject | Cell–Growth Profiling | en_US |
| dc.subject | Functional Assays | en_US |
| dc.subject | Label–Free Biosensing | en_US |
| dc.subject | Nanohole Arrays | en_US |
| dc.subject | Plasmonics | en_US |
| dc.title | Plasmonic Functional Assay Platform for Measuring Single Cell Growth through Refractive Index Sensing | |
| dc.title | Plasmonic Functional Assay Platform for Measuring Single Cell Growth through Refractive Index Sensing | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication | |
| gdc.author.scopusid | 58242821000 | |
| gdc.author.scopusid | 36612616900 | |
| gdc.author.scopusid | 35777178800 | |
| gdc.author.scopusid | 6602921939 | |
| gdc.author.scopusid | 35291427500 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::conference output | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology | en_US |
| gdc.description.departmenttemp | [Avci] Meryem Beyza, Izmir Biomedicine and Genome Center, Izmir, Izmir, Turkey; [Topkaya] Seda Nur, Department of Analytical Chemistry, İzmir Kâtip Çelebi Üniversitesi, Izmir, Turkey; [Yalcin-Ozuysal] Özden, Department of Molecular Biology and Genetics, Izmir Yüksek Teknoloji Enstitüsü, Izmir, Turkey; [Khademhosseini] Ali U., Terasaki Institute for Biomedical Innovation, Los Angeles, CA, United States; [Çetin] Arif Engin, Izmir Biomedicine and Genome Center, Izmir, Izmir, Turkey | en_US |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | N/A | |
| gdc.description.volume | 12627 | en_US |
| gdc.description.woscitationindex | Conference Proceedings Citation Index - Science | |
| gdc.description.wosquality | N/A | |
| gdc.identifier.openalex | W4386119322 | |
| gdc.identifier.wos | WOS:001066712600054 | |
| gdc.index.type | Scopus | |
| gdc.index.type | WoS | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.635068E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.popularity | 2.588463E-9 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.28 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 2 | |
| gdc.plumx.scopuscites | 0 | |
| gdc.scopus.citedcount | 0 | |
| gdc.wos.citedcount | 1 | |
| relation.isAuthorOfPublication.latestForDiscovery | f009792b-87b4-4bc1-88fc-fb55aa7f481c | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4003-8abe-a4dfe192da5e |
